Navigation Links
Chindex and Fosun Pharma Form Joint Venture
Date:12/28/2010

oducts in China. Sinopharm Group listed on the Hong Kong Stock Exchange in 2009, which ranks first and third in China and the world, respectively, in the pharmaceutical distribution field. Fosun Pharma's principal executive office is located in Shanghai, China. For more information, please visit   http://www.fosunpharma.com.

Forward-Looking Statements

Certain statements in this release may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.  In addition, we or our representatives have made or continue to make forward-looking statements, orally or in writing, in other contexts.  These forward-looking statements generally can be identified by the use of terminology such as "may," "will," "expect," "intend," "estimate," "anticipate," "plan," "foresee," "believe" or "continue" and similar expressions, or as other statements that do not relate solely to historical facts. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict or quantify.  Management believes these statements to be reasonable when made. However, actual outcomes and results may differ materially from what is expressed or forecasted in these forward-looking statements. As a result, these statements speak only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In view of such uncertainties, investors should not place undue reliance on our forward-looking statements. Such forward-looking statements involve known and unknown risks, including, but not limited to, those identified in "Risk Factors" in the Company's filings with the SEC, to which we refer you. These risks also include without limitation that there can be no assurance that the Company will fully consumma
'/>"/>

SOURCE Chindex International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2011 Financial Results
2. Fosun Pharma Acquires $14 Million of Chindex Stock
3. Chindex International to Report First Quarter 2011 Financial Results
4. Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results
5. Chindex International to Report Third Quarter Fiscal Year 2010 Financial Results
6. Chindex International to Present at Piper Jaffray Health Care Conference
7. Chindex International Announces Participation in Brean Murray, Carret & Co. 2009 China Growth Conference
8. Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results
9. Chindex International, Inc. to Report Second Quarter Fiscal 2010 Financial Results
10. Tongjitang Chinese Medicines Enters into Merger Agreement with Tonsun International Company Limited, Hanmax Investment Limited and Fosun Industrial Co., Limited
11. Caraco Pharmaceutical Laboratories, Ltd. Announces Extension and Future Termination of Distribution Agreements with Sun Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)...  Restore Health, a leading personalized medicine company ... it is now offering pharmacogenetics testing that provides ... upon their particular genetic makeup. Comprehensive medication management ... a patient,s genetics and their entire drug regimen.  ... this new service to healthcare providers and their ...
(Date:7/24/2014)... , and MARSEILLE, France , ... , Exclusive global license from University of Tokyo enables ... sequencing (NGS) gene panels, for blood cancers  ... test, indicate favorable prognosis for patients with bone marrow ... potential for developing companion diagnostics to guide treatment with ...
(Date:7/24/2014)... July 24, 2014  Abaxis, Inc. (NasdaqGS: ... analysis systems, today reported financial results for the first ... quarter overview: , Revenues of $47.5 million, up ... EPS of $0.21, up 50% over last year,s comparable ... revenues of $7.2 million, up 20% over last year,s ...
Breaking Medicine Technology:Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 2Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 3QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 2QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 3QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 4QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 8Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 9Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 10Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 11
... the nation seeks to expand health care coverage ... from Harvard University, Brigham and Women,s Hospital and ... that preventative health care may be significantly less ... of cost-effective generic medications for the treatment and ...
... July 7, 2011 ,   ... Yttrium-90 Resin Microspheres (ENRY),analysis of the long-term outcomes related ... with inoperable,primary liver tumours were published on-line today in, ... the Study of Liver,Diseases. [ 1 ] ...
Cached Medicine Technology:CVS Caremark, Harvard and Brigham and Women's Research Shows Generic Medications are Changing the Economics of Treating Chronically Ill Patients 2CVS Caremark, Harvard and Brigham and Women's Research Shows Generic Medications are Changing the Economics of Treating Chronically Ill Patients 3CVS Caremark, Harvard and Brigham and Women's Research Shows Generic Medications are Changing the Economics of Treating Chronically Ill Patients 4Largest Multi-Centre Evaluation of Radioembolization Using Sir-Spheres for Patients With Inoperable Primary Liver Cancer Published in Hepatology 2Largest Multi-Centre Evaluation of Radioembolization Using Sir-Spheres for Patients With Inoperable Primary Liver Cancer Published in Hepatology 3Largest Multi-Centre Evaluation of Radioembolization Using Sir-Spheres for Patients With Inoperable Primary Liver Cancer Published in Hepatology 4Largest Multi-Centre Evaluation of Radioembolization Using Sir-Spheres for Patients With Inoperable Primary Liver Cancer Published in Hepatology 5
(Date:7/25/2014)... York, US (PRWEB) July 25, 2014 ... global provider of technology-enabled services for the financial, ... that its virtual data room business, Merrill DataSite, ... the Year” presented by GrowthBusiness at the M&A ... Awards recognize the achievements of entrepreneurs, management teams, ...
(Date:7/25/2014)... A new study of participants in the National Lung ... in Cancer , found evidence that men and women ... abnormal finding on a lung cancer screening test did not ... those who were screened and found to be cancer-free. ... “We expected that participants with an abnormal finding would be ...
(Date:7/25/2014)... Hastings and Hastings, a ... with regard to personal injury claims, announces free initial ... of legal services for those that have been injured ... or corporation. Free initial consultation services gives clients’ greater ... potential personal injury claim . It also offers ...
(Date:7/25/2014)... (HealthDay --, Treatment for lymphoma may lower men,s fertility, ... lymphoma, which are cancers of the body,s white blood ... their reproductive years. For men, treatment for these cancers ... regain their fertility within two years of treatment, the ... possibility of this significant side effect before treatment begins. ...
(Date:7/25/2014)... Parkulture is proud to announce ... instructor, Jared “JJ” Woods, will be competing on NBC’s ... Warrior. The show will premiere on local affiliates this ... on the new Esquire Network on Tuesday, July 29th ... been balancing careers as a professional stuntman for film ...
Breaking Medicine News(10 mins):Health News:Merrill DataSite Recognized as “Technology Provider of the Year” by GrowthBusiness at the M&A Awards 2014 Event 2Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 2Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 3Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 4Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 5Health News:Hastings and Hastings Announces Complimentary Consultation Services 2Health News:Hastings and Hastings Announces Complimentary Consultation Services 3Health News:Lymphoma Treatment May Harm, Halt Men's Sperm Production 2Health News:Jared “JJ” Woods Prepares for American Ninja Warrior City Finals 2Health News:Jared “JJ” Woods Prepares for American Ninja Warrior City Finals 3
... catches on with yet another research study which says that eating ... in children. // , ,Researchers found that kids who ate ... have asthma attacks and wheezing. Other takeaway food and fizzy drinks ... ate at least one hamburger a week were 75 percent more ...
... the walls of a patient's room have been found ... and rheumatic complaints, a study says.//,A study group attached ... in medicated rooms were cured in shorter less time ... involved 36 patients, of whom 19 were kept in ...
... new medical device that is believed to allow bone ... quantities to permit far more research and allow faster ... difficulties in the growth and transplantation of stem cells. ... mimic conditions encountered by adult stem cells within the ...
... to tackle the issue of vaccination against Japanese Encephalitis ... country where the vaccine is available in a sizeable ... in Uttar Pradesh and Bihar has prompted the initiative ... also planned for detailed discussions with the Chinese minister ...
... Justice Silber is to give his verdict over the right ... consent or knowledge. The case which has been brought by ... pregnant. // ,The family planning association told the ... about contraception use and abortion does not match the views ...
... which could eventually lead to a practical and cost effective ... US National Cancer Institute have genetically modified bacteria living in ... // ,Most HIV transmission occurs on the surfaces ... with a layer of bacteria. ,The researchers have ...
Cached Medicine News:Health News:A warning for children consuming hamburgers: Asthma 2Health News:Now medicated coir to cure ailments 2Health News:Perfusion bioreactor could enhance stem cell research and application in the future 2Health News:Indian Government Keen On JE Vaccine Supply And Patenting Of Indian Medicine Formulations 2Health News:Genetically modified bacteria to combat HIV 2
... BRO-YP2 is Fujinon's pediatric ... outside diameter allows for ... The standard 2.0mm channel ... accessory passage in all ...
... from the latest 60 series bronchoscopes., ... range, focussing on providing clinicians with ... Olympus has a impressive range of ... in the respiratory tract to meet ...
... High performance fiberoptic imaging from ... ,Olympus has improved its fiberscope range, ... specifications and enhanced image performance. Olympus ... instruments for diagnosis and therapy in ...
Slim bronchoscope designed for paediatric applications....
Medicine Products: